162 related articles for article (PubMed ID: 12135859)
21. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
[TBL] [Abstract][Full Text] [Related]
22. A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expression.
Rosen J; He M; Umbricht C; Alexander HR; Dackiw AP; Zeiger MA; Libutti SK
Surgery; 2005 Dec; 138(6):1050-6; discussion 1056-7. PubMed ID: 16360390
[TBL] [Abstract][Full Text] [Related]
23. Genetic mutations in thyroid carcinoma.
Taccaliti A; Boscaro M
Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
[TBL] [Abstract][Full Text] [Related]
24. Follicular thyroid carcinoma: chromosome analysis of 19 cases.
Roque L; Clode A; Belge G; Pinto A; Bartnitzke S; Santos JR; Thode B; Bullerdiek J; Castedo S; Soares J
Genes Chromosomes Cancer; 1998 Mar; 21(3):250-5. PubMed ID: 9523201
[TBL] [Abstract][Full Text] [Related]
25. [Medullary thyroid carcinoma and some of its particularities].
Sidibé el H
Sante; 2007; 17(1):51-5. PubMed ID: 17897902
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive conventional and molecular cytogenetic characterization of B-CPAP, a human papillary thyroid carcinoma-derived cell line.
Dettori T; Frau DV; Garcia JL; Pierantoni G; Lee C; Hernandez JM; Fusco A; Morton CC; Vanni R
Cancer Genet Cytogenet; 2004 Jun; 151(2):171-7. PubMed ID: 15172756
[TBL] [Abstract][Full Text] [Related]
27. Identification of a gene rearranged by 2p21 aberrations in thyroid adenomas.
Rippe V; Drieschner N; Meiboom M; Murua Escobar H; Bonk U; Belge G; Bullerdiek J
Oncogene; 2003 Sep; 22(38):6111-4. PubMed ID: 12955091
[TBL] [Abstract][Full Text] [Related]
28. Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers.
Herrmann MA; Hay ID; Bartelt DH; Ritland SR; Dahl RJ; Grant CS; Jenkins RB
J Clin Invest; 1991 Nov; 88(5):1596-604. PubMed ID: 1939648
[TBL] [Abstract][Full Text] [Related]
29. Common pattern of unusual chromosome abnormalities in hereditary papillary renal carcinoma.
Prat E; Bernués M; Del Rey J; Camps J; Ponsa I; Algaba F; Egozcue J; Caballín MR; Gelabert A; Miró R
Cancer Genet Cytogenet; 2006 Jan; 164(2):142-7. PubMed ID: 16434318
[TBL] [Abstract][Full Text] [Related]
30. Toxicology and Carcinogenesis Studies of C.I. Pigment Red 3 (CAS No. 2425-85-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1992 Mar; 407():1-289. PubMed ID: 12621523
[TBL] [Abstract][Full Text] [Related]
31. An overview of molecular abnormalities leading to thyroid carcinogenesis: a 1993 perspective.
Gagel RF
Stem Cells; 1997; 15 Suppl 2():7-13. PubMed ID: 9368282
[TBL] [Abstract][Full Text] [Related]
32. Familial thyroid carcinoma: a diagnostic algorithm.
Dotto J; Nosé V
Adv Anat Pathol; 2008 Nov; 15(6):332-49. PubMed ID: 18948764
[TBL] [Abstract][Full Text] [Related]
33. Thyroid disorders. Part III: neoplastic thyroid disease.
Little JW
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Sep; 102(3):275-80. PubMed ID: 16920533
[TBL] [Abstract][Full Text] [Related]
34. Differential loss of heterozygosity in the region of the Cowden locus within 10q22-23 in follicular thyroid adenomas and carcinomas.
Marsh DJ; Zheng Z; Zedenius J; Kremer H; Padberg GW; Larsson C; Longy M; Eng C
Cancer Res; 1997 Feb; 57(3):500-3. PubMed ID: 9012481
[TBL] [Abstract][Full Text] [Related]
35. A domain of the thyroid adenoma associated gene (THADA) conserved in vertebrates becomes destroyed by chromosomal rearrangements observed in thyroid adenomas.
Drieschner N; Kerschling S; Soller JT; Rippe V; Belge G; Bullerdiek J; Nimzyk R
Gene; 2007 Nov; 403(1-2):110-7. PubMed ID: 17889454
[TBL] [Abstract][Full Text] [Related]
36. Karyotypic characterization of papillary thyroid carcinomas.
Roque L; Nunes VM; Ribeiro C; Martins C; Soares J
Cancer; 2001 Nov; 92(10):2529-38. PubMed ID: 11745186
[TBL] [Abstract][Full Text] [Related]
37. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
38. [Loss of heterozygosity on chromosome 3p in thyroid tumors].
Hu MJ; Xu HD; Zhou R; Li XF; Zhang HY
Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):305-8. PubMed ID: 18956647
[TBL] [Abstract][Full Text] [Related]
39. Numerical chromosomal aberrations in papillary renal cortical tumors: relationship with histopathologic features.
Henke RP; Erbersdobler A
Virchows Arch; 2002 Jun; 440(6):604-9. PubMed ID: 12070600
[TBL] [Abstract][Full Text] [Related]
40. DNA copy number changes in thyroid carcinoma.
Hemmer S; Wasenius VM; Knuutila S; Franssila K; Joensuu H
Am J Pathol; 1999 May; 154(5):1539-47. PubMed ID: 10329606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]